HOWL
HOWL
US95075A1079
Werewolf Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- 1.885.000
--
Cost of Revenue -- --
--
Gross Profit -- --
--
60.677.000 75.479.000
19.6%
Operating Income -60.677.000 -73.594.000
17.6%
Pretax Income -60.822.000 -70.515.000
13.7%
Net Income Common Stockholders -60.822.000 -70.515.000
13.7%
-- --
--
-- --
--
ende